Therapeutic Advances in Childhood Leukemia Consortium

Organisation

Trials

  • NCT07748689

    Phase 2, Not yet recruiting, 228 people, 6 Aug 2026

  • NCT07686107

    Phase 2, Not yet recruiting, 24 people, 7 Jul 2026

  • NCT05849662

    Phase 1/2, Recruiting, 58 people, 9 May 2023

  • NCT05600426

    Collaborator, Phase 3, Active, not recruiting, 53 people, 31 Oct 2022

  • NCT05476770

    Phase 1, Recruiting, 54 people, 27 Jul 2022

  • NCT03817320

    Phase 1/2, Active, not recruiting, 24 people, 25 Jan 2019

  • NCT03263936

    Phase 1, Completed, 37 people, 28 Aug 2017

  • NCT01861002

    Phase 1, Completed, 15 people, 23 May 2013

  • NCT01614197

    Phase 1, Completed, 16 people, 7 Jun 2012

  • NCT01483690

    Phase 1/2, Terminated, 23 people, 1 Dec 2011

  • NCT01411267

    Phase 1, Completed, 24 people, 8 Aug 2011

  • NCT01186328

    Phase 1, Terminated, 6 people, 23 Aug 2010

  • NCT01158885

    Phase 2, Terminated, 2 people, 8 Jul 2010

  • NCT01041508

    Phase 1, Completed, 18 people, 31 Dec 2009

  • NCT00981799

    Phase 1/2, Terminated, 23 people, 22 Sept 2009

  • NCT00939653

    Phase 2, Terminated, 6 people, 15 Jul 2009

  • NCT00928200

    Phase 1, Terminated, 1 person, 25 Jun 2009

  • NCT00440726

    Phase 1/2, Completed, 31 people, 27 Feb 2007

  • NCT00439296

    Phase 1/2, Terminated, 9 people, 23 Feb 2007